Clinical Efficacy of Ustekinumab in Crohn's Disease
ConditionCrohn's Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKazakhstan Scientific Society for Study of intestine diseases
About this trial
Clinical Efficacy of Ustekinumab in Crohn's Disease: an Observational Study With Retrospective and Prospective Components.
Eligibility criteria
Qualifiers
Patients aged 18 years and older;
Patients who were first prescribed Ustekinumab between January 1 and December 31, 2024
Patients who provided written informed consent to participate in the study
Disqualifiers
Clinically significant active infection (active tuberculosis, active viral hepatitis);
Pregnancy and lactation;
A history of clinically significant, in the opinion of the investigator, psychiatric disorders that may interfere with the study procedures and compliance with the drug regimen;
Ulcerative colitis;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov